Ocular tracking technology

Alcon has announced the acquisition of the ophthalmic division of SensoMotoric Instruments (SMI), a private company based in Berlin, Germany. Alcon said the acquisition provides it with leading ocular surgical guidance technology, such as realtime eye tracking, automatic registration of ocular imaging, and intraocular lens (IOL) positioning and alignment guidance, in order to help improve patient outcomes in cataract surgery. Alcon plans to integrate the newly acquired ocular surgical guidance technology into its existing global cataract portfolio. “This acquisition further strengthens Alcon’s position in the cataract surgery market with an expansion into leading ocular tracking technology,†said Sabri Markabi, senior vice-president, research and development at Alcon. “The state-of-theart guidance technology provides surgeons with customisation options and automated solutions, enabling optimal outcomes for their cataract patients including underlying refractive conditions.â€
• www.alcon.com
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.
Should Fuchs’ Dystrophy Patients Get Premium Lenses?
Patients’ demand for premium IOLs despite contraindications pose a challenge in Fuchs’ dystrophy treatment.
Avoiding Posterior Capsule Rupture
Imaging may help, but surgical technique is key for managing posterior polar cataracts.